Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0010718C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.